These findings and the fact that uPA/uPAR associates with resistance to therapy, suggest that the effect of SERPINE1 on tumor progression and drug resistance may be due to the activation of several signaling pathways that are independent from the inhibition of PA. The gene discussed is SERPINE1; the disease is neoplasm.